An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions
Clinical trial NCT05839951 · COMPLETED
Trial details
- NCT number
- NCT05839951
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-24
- Primary completion
- 2025-04-30
- Enrollment
- 818
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.